Wix.com stock price rises against the market trend

robot
Abstract generation in progress

Investing.com – Wix.com Ltd. (NASDAQ:WIX) shares rose 2% on Thursday, bucking a soft market as the S&P 500 fell 1.4%, after the company reported initial results of a revised Dutch auction tender offer.

The stock closed on Wednesday at $90.50, and the company then issued this announcement.

According to the initial tally by the tender offer escrow agent, Equiniti Trust Company, a total of 18,718,009 shares were formally tendered at a purchase price of $92.00 per share or below and have not been withdrawn. The tender offer expired one minute after 11:59 p.m. New York time on April 1, 2026.

Wix expects to purchase all 18,718,009 shares that were formally tendered and not withdrawn, at a purchase price of $92.00 per share, for total cost of approximately $1.722 billion, excluding fees and expenses. These shares represent approximately 31.6% of the number of shares outstanding as of April 1, 2026.

The number of shares to be acquired and the acquisition price are based on preliminary data and may change before confirmation by the escrow agent. The preliminary information is based on the following assumptions: all shares tendered through delivery instructions will be delivered within one trading day settlement period.

The final number of shares to be acquired and the final acquisition price will be announced after the expiration of the guaranteed delivery period and completion of the confirmation process. Payment for shares accepted in the tender offer will be made immediately thereafter.

This article was translated with the assistance of AI. For more information, please see our Terms of Use.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments